Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 3 studies | 19% ± 2% | |
epithelial cell | 3 studies | 28% ± 7% | |
fibroblast | 3 studies | 26% ± 12% |
Insufficient scRNA-seq data for expression of POLR2M at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2114.35 | 1445 / 1445 | 100% | 16.50 | 183 / 183 |
ovary | 100% | 2851.66 | 180 / 180 | 100% | 15.10 | 430 / 430 |
prostate | 100% | 3049.10 | 245 / 245 | 100% | 21.18 | 502 / 502 |
brain | 100% | 2771.85 | 2641 / 2642 | 100% | 19.46 | 705 / 705 |
thymus | 100% | 2520.39 | 653 / 653 | 100% | 21.96 | 604 / 605 |
lung | 100% | 2226.82 | 577 / 578 | 100% | 12.26 | 1154 / 1155 |
breast | 100% | 2770.66 | 459 / 459 | 100% | 12.89 | 1114 / 1118 |
kidney | 100% | 1891.55 | 89 / 89 | 99% | 13.55 | 892 / 901 |
uterus | 100% | 4294.75 | 170 / 170 | 99% | 12.20 | 453 / 459 |
pancreas | 99% | 1426.33 | 326 / 328 | 99% | 10.38 | 176 / 178 |
adrenal gland | 100% | 2328.52 | 258 / 258 | 98% | 15.14 | 225 / 230 |
bladder | 100% | 2677.14 | 21 / 21 | 98% | 10.11 | 493 / 504 |
intestine | 100% | 2099.24 | 966 / 966 | 96% | 10.34 | 507 / 527 |
stomach | 100% | 1564.61 | 359 / 359 | 96% | 11.28 | 275 / 286 |
skin | 100% | 2537.60 | 1807 / 1809 | 95% | 12.35 | 447 / 472 |
liver | 99% | 872.08 | 224 / 226 | 81% | 5.17 | 330 / 406 |
adipose | 100% | 3124.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4330.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.75 | 29 / 29 |
muscle | 100% | 2955.08 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1599.15 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.54 | 1 / 1 |
heart | 98% | 2385.66 | 847 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.95 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 95% | 8.97 | 76 / 80 |
peripheral blood | 60% | 984.42 | 553 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0051685 | Biological process | maintenance of ER location |
GO_0097550 | Cellular component | transcription preinitiation complex |
GO_0016591 | Cellular component | RNA polymerase II, holoenzyme |
GO_0031674 | Cellular component | I band |
GO_0005665 | Cellular component | RNA polymerase II, core complex |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0003711 | Molecular function | transcription elongation factor activity |
Gene name | POLR2M |
Protein name | DNA-directed RNA polymerase II subunit GRINL1A, isoforms 4/5 (DNA-directed RNA polymerase II subunit M, isoforms 4/5) DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A) RNA polymerase II subunit M |
Synonyms | GRINL1A |
Description | FUNCTION: [Isoform 1]: Appears to be a stable component of the Pol II(G) complex form of RNA polymerase II (Pol II). Pol II synthesizes mRNA precursors and many functional non-coding RNAs and is the central component of the basal RNA polymerase II transcription machinery. May play a role in the Mediator complex-dependent regulation of transcription activation. Acts as a negative regulator of transcriptional activation; this repression is relieved by the Mediator complex, which restores Pol II(G) activator-dependent transcription to a level equivalent to that of Pol II. . |
Accessions | ENST00000482852.5 [P0CAP2-3] P0CAP2 ENST00000380557.4 [P0CAP2-2] ENST00000299638.8 [P0CAP2-1] ENST00000464277.2 ENST00000494490.2 E9PP13 Q6EEV4 ENST00000649091.1 [Q6EEV4-2] |